Page last updated: 2024-11-05

tolbutamide and Craniopharyngioma, Adamantinous

tolbutamide has been researched along with Craniopharyngioma, Adamantinous in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"To elucidate the mechanism for growth following surgery in children with craniopharyngioma, serum somatomedin and prolactin levels, and plasma insulin (IRI) levels in response to oral glucose and intravenous tolbutamide, were determined in 5 and 8 children, respectively, at variable intervals following removal of the tumor."3.65Craniopharyngioma: the role of insulin in promoting postoperative growth. ( Costin, G; Daughaday, WH; Kogut, MD; Phillips, LS, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costin, G1
Kogut, MD1
Phillips, LS1
Daughaday, WH1

Other Studies

1 other study available for tolbutamide and Craniopharyngioma, Adamantinous

ArticleYear
Craniopharyngioma: the role of insulin in promoting postoperative growth.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 42, Issue:2

    Topics: Antigens; Blood Glucose; Carbohydrate Metabolism; Child; Child, Preschool; Craniopharyngioma; Endocr

1976